99
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Retinoic Acid-induced Cell Cycle Arrest of Human Myeloid Cell Lines

&
Pages 1641-1650 | Published online: 16 Nov 2010

References

  • Collins, S.J., Gallo, R.C. and Gallagher, RE. (1977) "Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture", Nature 270, 347–349.
  • Sundström, C. and Nilsson, K. (1976) "Establishment and characterization of a human histiocytic lymphoma cell line (U-937)", int. J. Cancer 17, 565–577.
  • Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F. and Berger, R. (1991) "NB4, a maturation inducible cell line with 1(15; 17) marker isolated from a human acute promyelocytic leukemia (M3)", Blood 77, 1080–1086.
  • Breitman, T.R., Selonick, S.E. and Collins, S.J. (1980) "Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid", Proc. Natl Acad. Sci. USA 77, 2936–2940.
  • Olsson, I.L, arid Breitman, T.R. (1982) "Induction of differentia-tion of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3', 5'-monophosphate-inducing agents", Cancer Res. 42, 3924–3927.
  • Warrell R.P. Jr, de The, H., Wang, Z.Y. and Degos, L. (1993) "Acute promyelocytic leukemia [see comments]", N. Engl. J.Med. 329, 177–189.
  • Dotting, J., Castro, D.S., Oberg, F., Nilsson, K. and Perlmann, T. (1997) "Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation", J. Biol. Chem. 272, 9443–9449.
  • Chambon, P. (1996) "A decade of molecular biology of retinoic acid receptors", Faseb. J. 10, 940–954.
  • Lin, R.J., Egan, D.A. and Evans, R.M. (1999) "Molecular genetics of acute promyelocytic leukemia", Trends Genet. 15, 179–184.
  • Grano., X. and Reddy, E.P. (1995) "Cell cycle control in manunalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)", Oncogene 11, 211–219.
  • Shimizu, T., Awai, N. and Takeda, K. (2000) "Complex regulation of CDICs and GI arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells", Oncogene 19, 4640–4646.
  • Oka, Y. and Takeda, K. (1997) "Retinoic acid combined with GM-CSF induces morphological changes with segmented nuclei in human myeloblastic leukemia ML-1 cells", Anticancer Res. 17, 1951–1955.
  • Dimberg, A., Bahram, F., Karlberg, I., Larsson, L.G., Nilsson, K. and ()berg, F. (2002) "Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and postuanscriptional up-regulation of p27(Kipl)", Blood 99, 2199–2206.
  • DiPietrantonio, A.M., Hsieh, T.C., Olson, S.C. and Wu, J.M. (1998) "Regulation of Gl/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR)", Int. J. Cancer 78, 53–61.
  • Sueoka, N., Lee, H.Y., Walsh, G.L., Hong, W.K. and Kurie, J.M. (1999) "Posuranslational mechanisms contribute to the suppres-sion of specific cyclin: CDK complexes by all-trans retinoic acid in human bronchial epithelial cells", Cancer Res. 59, 3838–3844.
  • Borriello, A., Pietra, V.D., Criscuolo, M., Oliva, A., Tonini, lolascon, A., Zappia, V. and Ragione, RD. (2000) "p271Cipl accumulation is associated with retinoic-induced neurobIastoma differentiation: evidence of a decreased proteasome-dependent degradation", Oncogene 19, 51–60.
  • Zhou, Q., Stetler-Stevenson, M. and Steeg, P.S. (1997) "Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro", Oncogene 15, 107–115.
  • Kaldis, P. (1999) "The cdk-activating kinase (CAK): from yeast to mammals", Cell. MoL Life Sci. 55, 284–296.
  • Wu, L., Chen, P., Shum, C.H., Chen, C., Barsky, L.W., Weinberg, K.I., Jong, A. and Triche, T.J. (2001) "MAT1-modulated CAK activity regulates cell cycle 0(1) exit", Mol. Cell. Biol. 21, 260–270.
  • Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.M. and Chambon, P. (1997) "Stimulation of RAR alpha activation function AF-I through binding to the general transcription factor THIN and phosphorylation by CDK7", Cell 90, 97–107.
  • Wang, J., Barsky, L.W., Shum, C.H., Jong, A., Weinberg, K.I., Collins, S.J., Triche, T.J. and Wu, L. (2002) "Retinoid-induced GI arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha", J. Bid. Chem, 277, 43369–43376.
  • Johnson, D.G. and Walker, C.L. (1999) "Cyclins and cell cycle checkpoints", Annu. Rev. PharmacoL Toxicol. 39, 295–312.
  • Roberts, J.M. (1999) "Evolving ideas about cyclins", Cell 98, 129–132.
  • Burger, C., Wick, M. and Mailer, R. (1994) "Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells", J. Cell. Sci. 107, 2047–2054.
  • Yang, R., Miller, C., Huynh, V., Fung, Y.K., Yee, A.S. and ICoeffler, H.P. (1999) "Functions of cyclin Al in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins", MoL Cell. Biol. 19, 2400–2407.
  • Milller, C., Yang, R., Park, D.J., Serve, H., Berdel, W.E. and Koerner, H.P. (2000) "The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin Al in acute promyelocytic leukemia", Blood 96, 3894–3899.
  • Yang, R., Morosetti, R. and Koerner, H.P. (1997) "Characteri-zation of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines", Cancer Res. 57, 913–920.
  • Yang, R., Nakamalci, T., Lubbert, M., Said, J., Sakashita, A., Freyaldenhoven, B.S., Spira, S., Huynh, V., Miller, C. and Koerner, H.P. (1999) "Cyclin Al expression in leukemia and normal hematopoietic cells", Blood 93, 2067–2074.
  • Langenfeld, J., Kiyokawa, H., SelcuIa, D., Boyle, J. and Dmitrovsky, E. (1997) "Posttranslational regulation of cyclin DI
  • Teixeira, C. and Pratt, M.A. (1997) "CDIC2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells", MoL EndocrinoL 11, 1191–1202.
  • Faria, T.N., LaRosa, G.J., Wilen, E., Liao, J. and Gudas, U. (1998) "Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest", Mot Cell. EndocrionoL 143, 155–166.
  • Kato, J.Y. and Sherr, C.J. (1993) "Inhibition of granulocyte differentiation by G1 cyclins 1)2 and D3 but not Dl", Proc. Nat! Acad. Sci. USA 90, 11513–11517.
  • Langenfeld, J., Lonardo, F., Kiyokawa, H., Passalaris, T., Ahn, M.J., Rusch, V. and Dmitrovsky, E. (1996) "Inhibited transfor-mation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation", Oncogene 13, 1983–1990.
  • Matsuo, T. and Thiele, C.J. (1998) "p27KipI: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line", Oncogene 16, 3337–3343.
  • Lee, H.Y. Dohi, D.F., Kim, Y.H., Walsh, G.L., Consoli, U., Andreeff, M., Dawson, M.I., Hong, W.K. and Kurie, J.M. (1998) "All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway", ./. Clin. Investig. 101, 1012–1019.
  • au, WY., Jones, C.S., Kiss, A., Matsulcuma, K., Amin, S. and De Luca, L.M. (1997) "Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells", Exp. Cell, Res. 234, 293–299.
  • Shen, C.J. and Roberts, J.M. (1999) "CDK inhibitors: positive and negative regulators of Gl-phase progression", Genes Dev. 13, 1501–1512.
  • Steinman, R.A. (2002) "Cell cycle regulators and hematopoiesis", Oncogene 21, 3403–3413.
  • Steinman, R.A., Hoffman, B., Ire, A., Guillouf, C., Liebermaim, D.A. and el-Houseini, M.E. (1994) "Induction of p21 (WAF-1/ CIP1) during differentiation", Oncogene 9, 3389–3396.
  • Jiang, H., Lin, J., Su, Z.Z., Collart, F.R., Huberman, E. and Fisher, P.B. (1994) "Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/C1P1, expression in the absence of p53", Oncogene 9, 3397–3406,
  • Liu, M., Iavarone, A. and Freedman, L.P. (1996) "Transcriptional activation of the human p21(WAFI/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation", Biol. Chem. 271, 31723–31728.
  • Bocchia, M., Xu, Q., Wesley, U., Xu, Y., Korontsvit, T., Loganzo, F., Albino, AP. and Scheinberg, D.A. (1997) "Modulation of p53, WAFI/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells", Leuk. Res. 21, 439–947.
  • Casini, T. and Pelicci, P.G. (1999) "A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest", Oncogene 18, 3235–3243.
  • Steinman, R.A., Huang, J., Yaroslavskiy, B., Goff, J.P., Ball, E.D. and Nguyen, A. (1998) "Regulation of p21(WAF1) expression during normal myeloid differentiation", Blood 91, 4531–4542.
  • Yang, W.L., Zeng, Y.X., El-Deiry, W.S., Nason-Burchenal, K., Dmitrovsky, E. and Chin, K.V. (1999) "Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalpha", MoL Cell. Biol. Res. Commun. 1, 125–131.
  • Wang, Z.G., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F. and Pandolfi, P.P. (1998) "Role of PML in cell growth and the retinoic acid pathway", Science 279, 1547–1551.
  • Liu, M., Lee, M.H., Cohen, M., Bomtnakanti, M. and Freedman, L.P. (1996) "Transcriptional activation of the Cdk inhibitor p21 by vitamin 133 leads to the induced differentiation of the myelomonocytic cell line U937", Genes Den 10, 142–153.
  • Matsumura, I., Ishikawa, J., Nakajima, K., Oritani, K., Tomiyatna, Y., Miyagawa, J., Kato, T., Miyazaki, H., Matsuzawa, Y. and Kanalana, Y. (1997) "Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAFI/Cipl ) by STAT5", MoL BioL 17, 2933–2943.
  • Yaroslavskiy, B., Watkins, S., Donnenberg, A.D., Patton, T.J. and Steinman, R.A. (1999) "Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells", Blood 93, 2907–2917.
  • Dow, R., Hendley, J., Pirkmaier, A., Musgrove, E.A. and Germain, D. (2001) "Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2", J. BioL Chem. 276, 45945–45951.
  • Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M. and Clurman, B.E. (1997) "Cyclin E-CDK2 is a regulator of p27Kip 1", Genes Dev. 11, 1464–1478.
  • Vlach, J., Hennecke, S. and Amati, B. (1997) "Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p77", Embo. J. 16, 5334–5344.
  • Taniguchi, T., Endo, H., Chikatsu, N., Uchimaru, K., Asano, S., Fujita, T., Nakahata, T, and Motokura, T. (1999) "Expression of p21(Cipl /Wafl/Sdil) and p27 (K ip 1 ) cyclin-dependentkinase inhibitors during human hematopoiesis", Blood 93, 4167–4178.
  • Muto, A., Kizaki, M., Yamato, K., Kawai, Y, Kamata-Matsushita, M., Ueno, H., Ohguchi, M., Nishihara, T., Koeffler, H.P. and Ikeda, Y. (1999) "1,25-Dihydroxyvitamin D3 induces differen-tiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21 (WAF1/CIP1) and p27(KIP1)", Blood 93, 2225–2233.
  • Teofili, L., Morosetti, R., Martini, M., Urbano, R., Putzulu, 11, Rutella, S., Pierelli, L., Leone, G. and Larocca, L.M. (2000) "Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation", Exp. HematoL 28, 519–526.
  • Reynisdottir, 1., Polyak, K., lavarone, A. and Massague, J. (1995) "Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta", Genes Den 9, 1831–1845.
  • Reynisdottir, I. and Massague, J. (1997) "The subcellular locations of p15(Ink4b) and p27(Kip 1 ) coordinate their inhibitory interac-tions with cdk4 and cdk2", Genes Den 11,492–503.
  • Thullberg, M., Bartkova, J., Khan, S., Hansen, K., Ronnstrand, L., Lukas, J., Strauss, M. and Bartek, J. (2000) "Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors", FEBS Lett. 470, 161–166.
  • Harbour, J.W. and Dean, D.C. (2000) "Rb function in cell-cycle regulation and apoptosis", Nat. Cell. BioL 2, E65—E67.
  • Classon, M. and Dyson, N. (2001) "p107 and p130: versatile proteins with interesting pockets", Exp. Cell. Res. 264, 135–147.
  • Trimarchi, J.M. and Lees, LA. (2002) "Sibling rivalry in the E2F family", Nat. Rev. MoL Cell. BioL 3, 11–20.
  • Knudsen, E.S. and Wang, J.Y. (1996) "Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites", J. BioL Chem. 271, 8313–8320.
  • Lundberg, A.S. and Weinberg, R.A. (1998) "Functional inacti-vation of the retinoblastoma protein requires sequential modifi-cation by at least two distinct cyclin-cdk complexes", MoL BioL 18, 753–761,
  • Harbour, J.W., Luo, R.X., Dei Sand. A., Postigo, A.A. and Dean, D.C. (1999) "Cdk phosphorylation triggers sequential intramole-cular interactions that progressively block Rb functions as cells move through GI", Cell 98, 859–869.
  • Chen, P.L., Scully, P., Shew, J.Y., Wang, J.Y. and Lee, W.H. (1989) "Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation", Cell 58, 1193–1198.
  • Mihara, K., Cao, X.R., Yen, A., Chandler, S., Driscoll, B., Murphree, A.L., T'Ang, A. and Fung, Y.K. (1989) "Cell cycle-dependent regulation of phosphorylation of the human retino-blastoma gene product", Science 246, 1300–1303.
  • Brooks, 3rd, S.C., Kazmer, S., Levin, A.A. and Yen, A. (1996) "Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor- selective retinoic acid analogs", Blood 87, 227–237.
  • Brooks, 3rd, S.C., Sturgill, R., Choi, J. and Yen, A. (1997) "An RXR-selective analog attenuates the RAR alpha-selective analog-induced differentiation and non-G1 -restricted growth arrest of N84 cells", Exp. Cell. Res. 234, 259–269.
  • Khanna-Gupta, A., Kolibaba, K., Zibello, T.A. and Berliner, N. (1994) "NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression", Blood 84, 294–302.
  • Khan, M.M., Nomura, T., Kim, H., Kaul, S.C., Wadhwa, R., Zhong, S., Pandolfi, P.P. and Ishii, S. (2001) "PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb", J. BioL Chem. 276, 43491–43494.
  • Thomas, N.S., Pizzey, A.R., Tiwari, S., Williams, C.D. and Yang, J. (1998) "p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon", J. Biol. Chem. 273, 23659–23667.
  • Juan, G., Li, X. and Darzynkiewicz, Z. (1998) "Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation", Exp. Cell, Res. 244, 83–92.
  • Condorelli, G.L., Testa, U., Valtieri, M., Vitelli, L., De Luca, A., Barberi, T., Montesoro, E., Campisi, S., Giordano, A. and Peschle, C. (1995) "Modulation of retinoblastoma gene in normal adult hematopoiesis: peak expression and functional role in advanced erythroid differentiation", Proc. Nat! Acad. ScL USA 92, 4808–4812.
  • Bergh, G., Ehinger, M., Olofsson, T., Baldetorp, B., Johnsson, E., Brycke, H., Lindgren, G., Olsson, L and Gullberg, U. (1997) "Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not GI-accumulation", Blood 89, 2938–2950.
  • Lipinski, M.M. and Jacks, T. (1999) "The retinoblastoma gene family in differentiation and development", Oncogene 18, 7873–7882.
  • Westin, E.H., Wong-Stant F., Gelmann,Dalla-Favera, R.,Papas, T.S., Lautenberger, J.A., Eva, A., Reddy, E.P., Tronick, S.R., Aaronson, S.A. and Gallo, R.C. (1982) "Expression of cellular homologues of retroviral one genes in human hemato-poietic cells", Proc. Nat! Acad, ScL USA 79, 2490–2494.
  • Grandori, C., Cowley, S.M., James, L.P. and Eisenman, R.N. (2000) "The Myc/Max/Mad network and the transcriptional control of cell behavior", Annu. Reu Cell. Den. Biol. 16,653–699.
  • Zhou, Z.Q. and Hurlin, P.J. (2001) "The interplay between Mad and Myc in proliferation and differentiation", Trends Cell. Biol. 11, S10—S14.
  • Henriksson, M. and Liischer, B. (1996) "Proteins of the Myc network: essential regulators of cell growth and differentiation", Adv. Cancer Res. 68, 109–182.
  • Einat, M., Resnitzky, D. and Kimchi, A. (1985) "Close link between reduction of c-myc expression by interferon and, GO/G1 arrest", Nature 313, 597–600.
  • Collins, S.J. (1987) "The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression", Blood 70, 1233–1244.
  • Barker, K.A. and Newburger, P.E. (1990) "Relationships between the cell cycle and the expression of c-myc and transfenin receptor genes during induced myeloid differentiation", Exp. Cell. Res. 186, 1–5.
  • Larsson, L.G., Pettersson, M., Oberg, F., Nilsson, K. and Luscher, B. (1994) "Expression of mad, mxi 1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc", Oncogene 9, 1247–1252.
  • Matikainen, S. and Hurme, M. (1994) "Comparison of retinoic acid and phorbol myristate acetate as inducers of monocytic differentiation", Int. J. Cancer 57, 98–103.
  • Robertson, K.A., Mueller, L. and Collins, S.J. (1991) "Retinoic acid receptors in myeloid leukemia: characterization of receptors in retinoic acid-resistant K-562 cells", Blood 77, 340–347.
  • Bentley, D.L. and Groudine, M. (1986) "A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells", Nature 321, 702–706.
  • Ishida, S., Shudo, K., Takada, S. and Koike, K. (1994) "Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins", Cell. Growth Differ 5, 287–294.
  • Johansen, L.M., lwama, A., Lodie, TA., Sasaki, K., Felsher, D.W., Golub, T.R. and Tenen, D.G. (2001) "c-Myc is a critical target for c/EBPalpha in granulopoiesis", MoL Cell. Biol. 21, 3789–3806.
  • Ramana, C.V., Grammatikakis, N., Chernov, M., Nguyen, H., Goh, K.C., Williams, B.R. and Stark, G.R. (2000) "Regulation of c-myc
  • Dimberg, A., Nilsson, K. and Oberg, F. (2000) "Phosphorylation-deficient Statl inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts", Blood 96, 2870–2878.
  • Shang, Y., Baumrucker, C.A. and Green, M.H. (1998) "c-Myc is a major mediator of the synergistic growth inhibitory effects of retinoic acid and interferon in breast cancer cells", .1. Biol. Chem. 273, 30608-30613_
  • Bahram, F., Wu, S., Oberg, F., Liischer, B. and Larsson, L.G. (1999) "Posuranslational regulation of Myc function in response to phorbol ester/interferon-gamma-induced differentiation of v-Myc-transformed U-937 monoblasts", Blood 93, 3900–3912.
  • Coppola, LA. and Cole, M.D. (1986) "Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment", Nature 320, 760–763.
  • Dmitrovsky, E., Kuehl, W.M., Hollis, G.F., Kirsch, I.R., Bender, T.P. and Segal, S. (1986) "Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythrol-eukaemia cell line", Nature 322, 748–750.
  • Prochownik, E.V. and Kukowska, J. (1986) "Deregulated expression of c-myc by mw-inc erythroleukaemia cells prevents differentiation", Nature 322, 848–850.
  • Larsson, L.G., Ivhed, I., Gidlund, M., Pettersson, U., Vennstrom, B. and Nilsson, K. (1988) "PhorboI ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene", Proc. Nail Acad. ScL USA 85, 2638–2642.
  • Hoffman-Liebermann, B, and Liebermann, D.A. (1991) "Inter-leukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leu.kemia cells is blocked at an intermediate stage by constitutive c-myc", MoL Cell. Biol. 11, 2375–2381.
  • Resnitzky, D. and Kimchi, A. (1991) "Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells", Cell. Growth Differ 2, 33–41.
  • Oberg, F., Larsson, L.G., Anton, R. and Nilsson, K. (1991) "Interferonabrogates the differentiation block in v-myc-expressing U-937 monoblasts", Proc. Nat! Acad. Sci. USA 88, 5567–5571.
  • Holt, J.T., Redner, R.L. and Nienhuis, A.W. (1988) "An oligomer complementary to c-myc InRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation", Mol. Cell. BioL 8, 963–973.
  • Collins, SJ., Robertson, K.A. and Mueller, L. (1990) "Retinoic acid-induced granulocytic differentiation of HL-60 myeloid
  • Ayer, D.E. and Eisenman, R.N. (1993) "A switch from Myc: Max to Mad:Max heterocomplexes accompanies monocyte/ macrophage differentiation", Genes Den 7, 2110–2119.
  • Cultraro, C.M., Bino, T. and Segal, S. (1997) "Function of the c-Myc antagonist Mad' during a molecular switch from proliferation to differentiation", MoL Cell. Biol. 17, 2353–2359.
  • Perez-Roger, I., Solomon, D.L., Sewing, A. and Land, H. (1997) "Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip I) binding to newly formed complexes", Oncogene 14, 2373–2381.
  • Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D. and Amati, B. (1996) "Growth arrest by the cyclin-dependent lcinase inhibitor p27Kipl is abrogated by c-Myc", EMBO. .1. 15, 6595–6604.
  • Perez-Roger, I., Kim, S.H., Griffiths, B., Sewing, A. and Land, H. (1999) "Cyclins DI and D2 mediate myc-induced proliferation via sequestration of p27(Kipl) and p21(Cipl)", EMBO .1. 18, 5310–5320.
  • Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinski, P., Bartek, J. and Eilers, M. (1999) "Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27", EMBO J. 18, 5321–5333.
  • Yang, W., Shen, J., Wu, M., Arsura, M., FitzGerald, M., Suldan, Z, Kim, D.W., Hofmann, CS., Pianetti, S., Romieu-Mourez, R., Freedman, L.P. and Sonenshein, G.E. (2001) "Repression of transcription of the p27(Kipl) cyclin-dependent lcinase inhibitor gene by c-Myc", Oncogene 20, 1688–1702.
  • McArthur, G.A., Foley, K.P., Fero, M.L., Walldey, CR., Deans, A.J., Roberts, J.M. and Eisenman, R.N. (2002) "MAD1 and p27 (KIP1) cooperate to promote terminal differentiation of granulo-cytes and to inhibit Myc expression and cyclin E-CDK2 activity", Mol. Cell. Biol. 22, 3014–3023.
  • Claassen, G.F. and Hann, S.R. (2000) "A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest", Proc. Nat! Acad. Sci. USA 97, 9498–9503.
  • Staller, P., Peukert, K., Kiennaier, A., Seoane, J., Lukas, J., Karsunky, H., Moroy, T., Bartek, J., Massague, J., Hanel, F. and Eilers, M. (2001) "Repression of pl5INK4b expression by Myc through association with Miz-l", Nat. Cell. Biol. 3, 392–399.
  • Dang, C.V. (1999) "c-Myc target genes involved in cell growth, apoptosis, and metabolism", Mol. Cell. BioL 19, 1–11.
  • Coller, H.A., Grandori, C., Tamayo, P., Colbert, T., Lander, ES., Eiseman, R.N. and Golub, T.R. (2000) "Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion", Proc. Nall Acad. Sci. USA 97, 3260–3265.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.